352 related articles for article (PubMed ID: 30706947)
1. Acinetobacter baumannii biofilm biomass mediates tolerance to cold plasma.
Flynn PB; Graham WG; Gilmore BF
Lett Appl Microbiol; 2019 Apr; 68(4):344-349. PubMed ID: 30706947
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces.
Greene C; Wu J; Rickard AH; Xi C
Lett Appl Microbiol; 2016 Oct; 63(4):233-9. PubMed ID: 27479925
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial action of 1,10-phenanthroline-based compounds on carbapenemase-producing Acinetobacter baumannii clinical strains: efficacy against planktonic- and biofilm-growing cells.
Ventura RF; Galdino ACM; Viganor L; Schuenck RP; Devereux M; McCann M; Santos ALS; Nunes APF
Braz J Microbiol; 2020 Dec; 51(4):1703-1710. PubMed ID: 32737867
[TBL] [Abstract][Full Text] [Related]
4. [Activity of tigecycline on planktonic and sessile cells of Acinetobacter baumannii].
Can F; Kaya M; Bayindir Bilman F; Uncu H; Demirbilek M; Yazici AC
Mikrobiyol Bul; 2009 Oct; 43(4):587-95. PubMed ID: 20084911
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Different Stages of Biofilm Formation and Antibiotic Susceptibility in a Clinical
Da Cunda P; Iribarnegaray V; Papa-Ezdra R; Bado I; González MJ; Zunino P; Vignoli R; Scavone P
Microb Drug Resist; 2020 Jun; 26(6):569-575. PubMed ID: 31895639
[No Abstract] [Full Text] [Related]
6. Acinetobacter baumannii Biofilm Formation: Association with Antimicrobial Resistance and Prolonged Survival under Desiccation.
Choudhary M; Shrivastava R; Vashistt J
Curr Microbiol; 2022 Oct; 79(12):361. PubMed ID: 36253556
[TBL] [Abstract][Full Text] [Related]
7. Acinetobacter baumannii isolated from hospital-acquired infection: biofilm production and drug susceptibility.
Krzyściak P; Chmielarczyk A; Pobiega M; Romaniszyn D; Wójkowska-Mach J
APMIS; 2017 Nov; 125(11):1017-1026. PubMed ID: 28913903
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
9. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces.
Espinal P; Martí S; Vila J
J Hosp Infect; 2012 Jan; 80(1):56-60. PubMed ID: 21975219
[TBL] [Abstract][Full Text] [Related]
10. Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro.
Liu Y; Mi Z; Niu W; An X; Yuan X; Liu H; Wang Y; Feng Y; Huang Y; Zhang X; Zhang Z; Fan H; Peng F; Li P; Tong Y; Bai C
Future Microbiol; 2016 Oct; 11():1383-1393. PubMed ID: 27538011
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Role of Cold-Shock Protein C: a Novel Regulator of Acinetobacter baumannii Biofilm Formation and Virulence.
Tomlinson BR; Denham GA; Torres NJ; Brzozowski RS; Allen JL; Jackson JK; Eswara PJ; Shaw LN
Infect Immun; 2022 Oct; 90(10):e0037622. PubMed ID: 36121221
[TBL] [Abstract][Full Text] [Related]
12. Biofilm Formation Caused by Clinical Acinetobacter baumannii Isolates Is Associated with Overexpression of the AdeFGH Efflux Pump.
He X; Lu F; Yuan F; Jiang D; Zhao P; Zhu J; Cheng H; Cao J; Lu G
Antimicrob Agents Chemother; 2015 Aug; 59(8):4817-25. PubMed ID: 26033730
[TBL] [Abstract][Full Text] [Related]
13. Desiccation and ethanol resistances of multidrug resistant Acinetobacter baumannii embedded in biofilm: The favorable antiseptic efficacy of combination chlorhexidine gluconate and ethanol.
Chiang SR; Jung F; Tang HJ; Chen CH; Chen CC; Chou HY; Chuang YC
J Microbiol Immunol Infect; 2018 Dec; 51(6):770-777. PubMed ID: 28732564
[TBL] [Abstract][Full Text] [Related]
14. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability.
Duarte A; Ferreira S; Almeida S; Domingues FC
Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918
[TBL] [Abstract][Full Text] [Related]
15. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
Tiwari V; Tiwari D; Patel V; Tiwari M
Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
[TBL] [Abstract][Full Text] [Related]
16. A Surfactant-Based Dressing to Treat and Prevent Acinetobacter baumannii Biofilms.
Yang Q; Schultz GS; Gibson DJ
J Burn Care Res; 2018 Aug; 39(5):766-770. PubMed ID: 29931339
[TBL] [Abstract][Full Text] [Related]
17. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates.
Bardbari AM; Arabestani MR; Karami M; Keramat F; Alikhani MY; Bagheri KP
Microb Pathog; 2017 Jul; 108():122-128. PubMed ID: 28457900
[TBL] [Abstract][Full Text] [Related]
18. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
[TBL] [Abstract][Full Text] [Related]
19. Decoding Acinetobacter baumannii biofilm dynamics and associated protein markers: proteomic and bioinformatics approach.
Choudhary M; Kaushik S; Kapil A; Shrivastava R; Vashistt J
Arch Microbiol; 2022 Mar; 204(4):200. PubMed ID: 35239017
[TBL] [Abstract][Full Text] [Related]
20. Persistence of Multidrug-Resistant Acinetobacter baumannii Isolates Harboring blaOXA-23 and bap for 5 Years.
Sung JY; Koo SH; Kim S; Kwon GC
J Microbiol Biotechnol; 2016 Aug; 26(8):1481-9. PubMed ID: 27221112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
